Clinical IQ, along with Working Buildings, is working with NIH to review their current facilities and processes to ensure patient’s are receiving the highest standard of care at all of NIH’s facilities. Click the article below to read about NIH and Clinical IQ’s efforts.
NIH Statement on NIH Clinical Center Improvement Plan
Click here to view: Moving Targets: An Update on Legislation and Standards Aimed at Ensuring the Quality of Pharmaceutical and Compounded Drug Products in the U.S. (3 hours ACPE-Approved CE)
During this webinar, you will learn about different conditions for compounding under sections 503A and 503B of the FDCA. It will discuss the evolving FDA oversight and emerging guidance on topics such as repackaging, and tools for hospitals looking to source from FDA-regulated outsourcing facilities. This webinar will also examine drug traceability law. In addition, this webinar will cover critical developments in USP standards.
General USP Chapter <797> Proposed Revision
General USP Chapter <800> Proposed Revision
FDA Registered Outsourcing Facilities
CriticalPoint® 2007-2017 CriticalPoint, LLC | Privacy | Terms of Use
973-256-6500